The proposed mechanism is that SARS-CoV-2 binds to angiotensin converting enzyme 2 (ACE2) receptors causing downregulation of ACE2, which might trigger inflammation and progression of BPH. Here, ACE2 is linked to benign prostatic hyperplasia.